Women remain underrepresented in cardiology despite a growing pipeline of female medical students and internal medicine resident physicians, according to a Sept. 11 report in JAMA Cardiology.

Chicago biotech company BIOLIFE4D announced this week it had successfully 3D-bioprinted a mini human heart—something the company noted as a “significant milestone” on the path to printing full-sized hearts viable for transplant.

Proven protocols and practices, people and a push for earlier hemodynamic support are changing the face of cardiogenic shock survival. One leading health system has improved survival rates into the 70+ percent range. And their team believes other facilities should follow suit.

The level of pragmatism in CV-related randomized clinical trials has only increased moderately over the past two decades, according to work published in JAMA Cardiology Sept. 1.

A team of researchers in Iran, the U.S. and the U.K. may have cracked the code of the elusive polypill, they reported after finding their four-drug concoction effectively reduced adverse CV events in nearly 3,500 patients.

Researchers on the International Space Station are leveraging the microgravity conditions within the ISS U.S. National Laboratory to study heart cells in ways we can’t on the ground.

Cerner Corporation has partnered with the Duke Clinical Research Institute to pilot the Cerner Learning Health Network, an evolving database that aims to automate data collection for rapid access to contemporary medical information.

There is new synergy afoot when it comes to enterprise imaging. Healthcare systems are increasingly choosing enterprise imaging systems to manage image viewing across the two most image-rich ‘ologies: radiology and cardiology.